Late-onset neutropenia following primary treatment of diff use large B-cell lymphoma with rituximab-containing therapy

References

• Dunleavy K, Hakim F, Kim HK, . B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood 2005;106: 795–802.
   PubMed Web of Science ®Google Scholar
• Ram R, Ben-Bassat I, Shpilberg O, . The late adverse events of rituximab therapy – rare but there. Leuk Lymphoma 2009;50:1083–1095.
   PubMed Web of Science ®Google Scholar
• Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 2003;30:3–8.
   PubMed Web of Science ®Google Scholar
• Molina A. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma. Annu Rev Med 2008;59:237–250.
   PubMed Web of Science ®Google Scholar
• Boye J, Elter T, Engert A. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 2003;14:520–535.
   PubMed Web of Science ®Google Scholar
• Chaiwatanatorn K, Lee N, Grigg A, . Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol 2003;121:913–918.
   PubMed Web of Science ®Google Scholar
• Rios-Fernandez R, Gutierrez-Salmeron MT, Callejas-Rubio JL, . Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases. Br J Dermatol 2007;157:1271–1273.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Spedini P, Casari S, . Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments. Leuk Lymphoma 2006;47:1013–1017.
   PubMed Web of Science ®Google Scholar
• Voog E, Morschhauser F, Solal-Celigny P. Neutropenia in patients treated with rituximab. N Engl J Med 2003;348:2691–2694.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Horning SJ, Coiffier B, . Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244–1253.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, . Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v4.03. 14 June 2010 [Internet]. Available from: http://ctep.cancer.gov/default.htm
   Google Scholar
• Nitta E, Izutsu K, Sato T, . A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma:s single-institution study. Ann Oncol 2007;18:364–369.
   PubMed Web of Science ®Google Scholar
• McLaughlin P. Late-onset neutropenia following rituximab. Leuk Lymphoma 2006;47:965–966.
   PubMed Web of Science ®Google Scholar
• Fukuno K, Tsurumi H, Ando N, . Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma. Int J Hematol 2006;84:242–247.
   PubMed Web of Science ®Google Scholar
• Lemieux B, Tartas S, Traulle C, . Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant 2004;33:921–923.
   PubMed Web of Science ®Google Scholar
• Lai GG, Lim ST, Tao M, . Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma. Am J Hematol 2009;84:414–417.
   PubMed Web of Science ®Google Scholar
• Li SC, Chen YC, Evens AM, . Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism. Am J Hematol 2010;85: 810–812.
   PubMed Web of Science ®Google Scholar
• Tesfa D, Gelius T, Sander B, . Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol 2008;25: 374–379.
   PubMed Web of Science ®Google Scholar
• Cairoli R, Grillo G, Tedeschi A, . High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation. Haematologica 2004;89:361–363.
   PubMed Web of Science ®Google Scholar
• Institute of Oncology Ljubljana. Smernice za obravnavo bolnikov z malignimi limfomi. January 2011 [Internet]. Available from: http://www.onko-i.si/uploads/media/Doktrina_2011.pdf
   Google Scholar
• Hincks I, Woodcock BE, Thachil J. Is rituximab-induced late-onset neutropenia a good prognostic indicator in lymphoproliferative disorders? Br J Haematol 2011;153:411–413.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Stavroyianni N, . Evidence for T-large granular lymphocyte-mediated neutropenia in rituximab-treated lymphoma patients: report of two cases. Leuk Res 2002;26: 597–600.
   PubMed Web of Science ®Google Scholar
• Coakley G, Iqbal M, Brooks D, . CD8 + , CD57 + T cells from healthy elderly subjects suppress neutrophil development in vitro: implication of Felty's and large granular lymphocyte syndromes. Arthritis Rheum 2000;43:834–843.
   PubMed Web of Science ®Google Scholar
• Tesfa D, Ajeganova S, Hagglund H, . Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthritis Rheum 2011;63: 2209–2214.
   PubMed Web of Science ®Google Scholar
• Terrier B, Ittah M, Tourneur L, . Late-onset neutropenia following rituximab results from hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica 2007;92:20–23.
   PubMed Web of Science ®Google Scholar
• Schneider P, MacKay F, Steiner V, . BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747–1756.
   PubMed Web of Science ®Google Scholar
• Koene HR, Kleijer M, Algra J, . Fc gammaRIIIa-158V/F polymorphisms influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 1997;90:1109–1114.
   PubMed Web of Science ®Google Scholar
• Keane C, Nourse JP, Crooks P, . Homozygous FCGR3a-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma. Intern Med J 2011 Sep 1. [Epub ahead of print]
   Web of Science ®Google Scholar